We are live on ! Find out more
BKYI

BIO-key International

5 hedge funds and large institutions have $371K invested in BIO-key International in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more capital invested

Capital invested by funds: $199K → $371K (+$172K)

0% less ownership

Funds ownership: 0%0% (-0%)

17% less funds holding

Funds holding: 65 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

BKYI Hedge Fund Activity: Q1 2019 in Review

5 of the 4,624 institutional investors tracked by Wall St. Rank reported a position in BIO-key International (BKYI) for Q1 2019, worth a combined $371K — up 86% from $199K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of BKYI and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 2 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $23.3K. The largest seller was Perkins Capital Management, exiting entirely with an estimated $19K sold.

  • 5 institutional investors held BIO-key International (BKYI) as of Q1 2019, down from 6 in Q4 2018.
  • Funds reported $371K of BIO-key International stock for Q1 2019, up 86% quarter-over-quarter.
  • 1 fund opened new BIO-key International positions in Q1 2019 and 2 closed out, a net change of -1 holder.
  • The largest BIO-key International buyer in Q1 2019 was Citadel Advisors, an estimated $23.3K added.
  • The largest BIO-key International seller in Q1 2019 was Perkins Capital Management, an estimated $19K sold.

Based on aggregated 13F filings for Q1 2019.